Kansai has a concentration of the top Japanese research institutes and companies in life sciences, where work is underway in various areas from health to drug discovery and treatment including regeneration medicine such as iPS cells, for which the Nobel Prize was awarded. Also, it is designated as an international strategic comprehensive special zone of the nation, where companies located in Kansai can benefit from regulatory and taxation benefits in the special zone.
At the Kansai International Airport as a hub airport in Kansai, alongside cool chain transport of pharmaceutical products and simplification of trade procedures for pharmaceutical products/medical devices, various efforts are being made for quality control and speed-up of trading pharmaceutical products/medical devices.
Efforts to match companies and research institutes in the life science area are actively promoted, which makes the region advantageous for companies looking to pursue business and R&D in this field in the future.
Thanks to Umeda’s excellent accessibility to universities and research institutes located in Kansai, companies in the field of life sciences are starting businesses in Umeda.
Also, in GRAND FRONT OSAKA located in Umeda, the Pharmaceuticals and Medical Devices Agency (PMDA) was established in Japan outside for Tokyo. A system to speed-up approval/examination of pharmaceutical products is developing.
Furthermore, Umeda is one of the areas designated as an international strategic comprehensive special zone of the nation, where companies that satisfy certain criteria in the area can receive incentives.